In this two-episode podcast miniseries, experts examine evolving concepts in anaphylaxis pathophysiology and diagnosis, age-specific and rapidly evolving presentations, and barriers to timely epinephrine use. The discussions highlight evidence-based approaches to recognition, acute management, prevention, and clinical decision-making as anaphylaxis care and epinephrine delivery options continue to evolve.

This activity is supported by an independent medical education grant from Aquestive Therapeutics, Inc.

Recorded October 28, 2026

Host: David R. Stukus, MD, FACAAI
Experts: David B.K. Golden, MD, FACAAI; Jay A. Lieberman, MD, FACAAI; Syed Shahzad Mustafa, MD, FACAAI

[audio players for both episodes] + [video players for both episodes]

Interested in claiming CME for this miniseries? Click here! [include link to CME course] 

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.